Johann Micallef

3.3k total citations · 2 hit papers
14 papers, 2.6k citations indexed

About

Johann Micallef is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Johann Micallef has authored 14 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Genetics. Recurrent topics in Johann Micallef's work include Glioma Diagnosis and Treatment (3 papers), RNA Research and Splicing (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Johann Micallef is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), RNA Research and Splicing (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Johann Micallef collaborates with scholars based in Canada, United States and China. Johann Micallef's co-authors include Abhijit Guha, Janusz Rak, Khalid Al‐Nedawi, Vladimir Lhotak, Linda May, Brian Meehan, Joydeep Mukherjee, Cynthia Hawkins, N. Sabha and Rob A. Cairns and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and Blood.

In The Last Decade

Johann Micallef

14 papers receiving 2.6k citations

Hit Papers

Intercellular transfer of the oncogenic receptor EGFRvIII... 2008 2026 2014 2020 2008 2011 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
    2008 1.6k citations Khalid Al‐Nedawi, Brian Meehan et al. Nature Cell Biology profile →
  2. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
    2011 622 citations Amparo Wolf, Sameer Agnihotri et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johann Micallef Canada 10 2.1k 1.5k 293 270 254 14 2.6k
Delphine Garnier Canada 26 1.3k 0.6× 828 0.6× 218 0.7× 329 1.2× 273 1.1× 44 2.1k
Vladimir Lhotak Canada 5 2.1k 1.0× 1.1k 0.8× 292 1.0× 246 0.9× 150 0.6× 6 2.8k
Nicolas Skuli United States 28 1.6k 0.7× 1.3k 0.9× 234 0.8× 444 1.6× 232 0.9× 45 2.6k
Francesca Margheri Italy 28 1.0k 0.5× 592 0.4× 303 1.0× 492 1.8× 163 0.6× 51 1.8k
Irene K. Yan United States 30 3.2k 1.5× 2.5k 1.7× 251 0.9× 247 0.9× 237 0.9× 63 4.0k
Sandra D’Ascenzo Italy 21 1.3k 0.6× 860 0.6× 288 1.0× 276 1.0× 60 0.2× 31 2.1k
Paulina Kucharzewska Poland 14 1.4k 0.6× 990 0.7× 241 0.8× 147 0.5× 119 0.5× 29 1.8k
Anna Sebestyén Hungary 22 1.1k 0.5× 518 0.4× 269 0.9× 464 1.7× 153 0.6× 103 1.9k
Nabendu Pore United States 17 1.4k 0.7× 1.1k 0.7× 244 0.8× 614 2.3× 181 0.7× 26 2.3k
Olav Engebraaten Norway 29 1.3k 0.6× 700 0.5× 331 1.1× 925 3.4× 289 1.1× 87 2.7k

Countries citing papers authored by Johann Micallef

Since Specialization
Citations

This map shows the geographic impact of Johann Micallef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johann Micallef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johann Micallef more than expected).

Fields of papers citing papers by Johann Micallef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johann Micallef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johann Micallef. The network helps show where Johann Micallef may publish in the future.

Co-authorship network of co-authors of Johann Micallef

This figure shows the co-authorship network connecting the top 25 collaborators of Johann Micallef. A scholar is included among the top collaborators of Johann Micallef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johann Micallef. Johann Micallef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Datta, Anita, et al.. (2021). Pediatric Occipital Spikes at a Single Center Over 26 Years and the Significance of Tangential Dipole. Journal of Child Neurology. 36(7). 530–536. 3 indexed citations
2.
Micallef, Johann, Sylvia Stöckler‐Ipsiroglu, Clara D.M. van Karnebeek, Ramona Salvarinova, & Gabriella Horváth. (2020). Recurrent Dystonic Crisis and Rhabdomyolysis Treated with Dantrolene in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency. Neuropediatrics. 51(3). 229–232. 2 indexed citations
3.
Gonorazky, Hernán, Minggao Liang, Beryl B. Cummings, et al.. (2015). RNA seq analysis for the diagnosis of muscular dystrophy. Annals of Clinical and Translational Neurology. 3(1). 55–60. 59 indexed citations
4.
Wolf, Amparo, Sameer Agnihotri, Johann Micallef, et al.. (2011). Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. The Journal of Experimental Medicine. 208(2). 313–326. 622 indexed citations breakdown →
5.
Wolf, Amparo, Sameer Agnihotri, Johann Micallef, et al.. (2011). Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. The Journal of Cell Biology. 192(2). i1–i1. 28 indexed citations
6.
Yang, Yijun, Johann Micallef, & Hong Chang. (2011). MARCKS Confers Resistance to Velcade Through Skp2/p27-Mediated Pathway in Multiple Myeloma. Blood. 118(21). 985–985. 1 indexed citations
7.
Micallef, Johann, Moyez Dharsee, Jian Chen, et al.. (2010). Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma. Journal of Hematology & Oncology. 3(1). 13–13. 17 indexed citations
8.
Micallef, Johann, Michael S. Taccone, Joydeep Mukherjee, et al.. (2009). Epidermal Growth Factor Receptor Variant III–Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression. Cancer Research. 69(19). 7548–7556. 67 indexed citations
9.
Saha, Manujendra N., Johann Micallef, Lugui Qiu, & Hong Chang. (2009). Pharmacological activation of the p53 pathway in haematological malignancies. Journal of Clinical Pathology. 63(3). 204–209. 40 indexed citations
10.
Mukherjee, Joydeep, Leroi V. DeSouza, Johann Micallef, et al.. (2009). Loss of Collapsin Response Mediator Protein1, as Detected by iTRAQ Analysis, Promotes Invasion of Human Gliomas Expressing Mutant EGFRvIII. Cancer Research. 69(22). 8545–8554. 27 indexed citations
11.
Al‐Nedawi, Khalid, Brian Meehan, Johann Micallef, et al.. (2008). Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nature Cell Biology. 10(5). 619–624. 1602 indexed citations breakdown →
12.
Milsom, Chlöe, Joanne Yu, Nigel Mackman, et al.. (2008). Tissue Factor Regulation by Epidermal Growth Factor Receptor and Epithelial-to-Mesenchymal Transitions: Effect on Tumor Initiation and Angiogenesis. Cancer Research. 68(24). 10068–10076. 129 indexed citations
13.
Micallef, Johann, Aaron S. Gajadhar, Joseph Wiley, et al.. (2008). PROTEOMICS. Neurosurgery. 62(3). 539–555. 6 indexed citations
14.
Laperrière, Normand, et al.. (2000). Quality of life in patients with glioblastoma participating in a randomized study of boost brachytherapy. Journal of neurosurgery. 93(6). 917–926. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Delphine Garnier Breakdown of academic impact, for papers by Vladimir Lhotak Breakdown of academic impact, for papers by Nicolas Skuli Breakdown of academic impact, for papers by Francesca Margheri Breakdown of academic impact, for papers by Irene K. Yan Breakdown of academic impact, for papers by Sandra D’Ascenzo Breakdown of academic impact, for papers by Paulina Kucharzewska Breakdown of academic impact, for papers by Anna Sebestyén Breakdown of academic impact, for papers by Nabendu Pore Breakdown of academic impact, for papers by Olav Engebraaten
Rankless by CCL
2026